Multiple myeloma: An update on biology and treatment-Reference-Cited by-同舟云学术

Multiple myeloma: An update on biology and treatment

Published:1999 Issue: Volume:10 Page:S31-S43
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ludwig H.,Meran J.,Zojer N.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/suppl_6/S31/7724403/10-suppl_6-S31.pdf

Reference132 articles.

1. Regulation of B-cell commitment to plasma cells or to memory B cells;Liu;Semin Immunol,1997

2. Key differentiation steps in normal B cells and in myeloma cells;Zubler;Semin Hematol,1997

3. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation;Bakkus;Blood,1992

4. Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene;Ralph;Blood,1993

5. Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity;Vescio;J Immunol,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloma;Atlas of Orthopedic Pathology;2008

2. Multiples Myelom;Der Internist;2003-04-05

3. Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3;British Journal of Cancer;2003-03

4. Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts;Blood;2002-08-15